Ads
related to: hearing loss after chemotherapy treatmentcochlear.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Ototoxicity-induced hearing loss typically impacts the high frequency range, affecting above 8000 Hz prior to impacting frequencies below. [8] There is not global consensus on measuring severity of ototoxicity-induced hearing loss as there are many criteria available to define and measure ototoxicity-induced hearing loss.
[6] [7] Specific side effects of platinum compounds include hearing loss, tinnitus, and dysesthesia. These symptoms generally begin with the or third cycle of treatment and can last long after treatment completion. Indeed, the “coasting” phenomenon mentioned in the Symptoms section is a direct effect of platinum agents. Of the platinum ...
This protective agent was also found to be associated with the survival of cochlear spiral ganglion neurones after hearing loss or deafness. [35] Audiological management can be implemented, for example, by providing hearing aids. In more seriously affected patients, cochlear implantation may be considered and discussed with the patient.
The FDA approved Fennec Pharmaceuticals Inc's (NASDAQ: FENC) Pedmark to reduce the risk of chemo-induced ototoxicity in pediatric patients. Pedmark is indicated for pediatric patients one month of ...
In this article, we’re taking a closer look at sensorineural hearing loss (SNHL) is, its causes, and potential treatments.
In September 2022, the U.S. Food and Drug Administration (FDA) approved sodium thiosulfate under the brand name Pedmark to lessen the risk of ototoxicity and hearing loss in infant, child, and adolescent cancer patients receiving the chemotherapy medication cisplatin. [3] [13] [14]
Ads
related to: hearing loss after chemotherapy treatmentcochlear.com has been visited by 10K+ users in the past month